Effect of S-adenosylmethionine on hepatic and metabolic disorders in guinea pigs with non-alcoholic steatohepatitis.

Creative Commons License

Bingül İ., Küçükgergin C., Aydın A. F., Çevik A., Soluk Tekkeşin M., Olgaç N. V., ...Daha Fazla

İstanbul Üniversitesi İstanbul Tıp Fakültesi Mecmuası, cilt.88, sa.1, ss.1-12, 2024 (Scopus)

Özet

ABSTRACT

Objective: S-adenosylmethionine (SAM) has antioxidant and anti-inflammatory actions and hepatoprotective potential. In this study, the therapeutic effectiveness of SAM was investigated in high-fat/cholesterol diet (HFCD)-induced non-alcoholic steatohepatitis (NASH).

Material and Methods: In this study, guinea pigs received a HFCD for ten weeks to develop NASH. SAM (50 mg/kg, i.p) was applied to animals in the last four weeks of the 10-week HFCD application. Hepatic damage markers, lipid levels (total cholesterol and triglyceride), inflammatory cytokines (tumor necrosis-α and interleukin-6) levels, and insulin resistance (HOMA-IR) were determined in the serum. Moreover, hepatic lipids, SAM and cytochrome p450-2E1 (CYP2E1) levels, prooxidant parameters (reactive oxygen species, lipid peroxides, and protein carbonyls), and antioxidant parameters (glutathione levels and antioxidant activity) together with fibrosis indicators (α-smooth muscle actin and transforming growth factor-β1 protein expressions and hydroxyproline levels) were investigated in the liver. Steatosis, inflammation, and fibrosis scores were also detected histopathologically.

Result: SAM treatment diminished the increase in hepatic damage markers, inflammatory cytokine levels, and HOMA-IR levels.